Cargando…

Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma

BACKGROUND: Bleomycin-induced lung injury, a major complication of chemotherapy for germ cell tumors, occasionally fails to respond to the standard treatment with corticosteroids and develops into severe respiratory insufficiency. Little is known about salvage treatment for refractory cases. CASE PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Koji, Ito, Satoru, Hashimoto, Naozumi, Hasegawa, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547483/
https://www.ncbi.nlm.nih.gov/pubmed/28784103
http://dx.doi.org/10.1186/s12885-017-3521-0
_version_ 1783255700023017472
author Sakamoto, Koji
Ito, Satoru
Hashimoto, Naozumi
Hasegawa, Yoshinori
author_facet Sakamoto, Koji
Ito, Satoru
Hashimoto, Naozumi
Hasegawa, Yoshinori
author_sort Sakamoto, Koji
collection PubMed
description BACKGROUND: Bleomycin-induced lung injury, a major complication of chemotherapy for germ cell tumors, occasionally fails to respond to the standard treatment with corticosteroids and develops into severe respiratory insufficiency. Little is known about salvage treatment for refractory cases. CASE PRESENTATION: A 63-year-old man who had been diagnosed with stage I seminoma and undergone a high orchiectomy 1 year previously developed swelling of his left iliac lymph node and was diagnosed with a recurrence of the seminoma. He was administered a standard chemotherapy regimen of cisplatin, etoposide, and bleomycin. At the end of second cycle, he developed a dry cough and fever that was accompanied by newly-identified bilateral infiltrates on chest X-ray. Despite initiation of oral prednisolone, his exertional dyspnea and decline in pulmonary functions continued to be aggravated. High-dose pulse treatment with methylprednisolone was introduced and improved his symptoms and radiologic findings. However, the maintenance dose of oral prednisolone allowed reactivation of the disease with evidence of newly-developed bilateral lung opacities on high-resolution CT scans. Considering his glucose intolerance and cataracts as complications of corticosteroid treatment, administration of pirfenidone was initiated with the patient’s consent. Pirfenidone at 1800 mg/day was well tolerated, and resolved his symptoms and abnormal opacities on a chest CT scan. Subsequently, the dose of prednisolone was gradually tapered without worsening of the disease. At the most recent follow-up, he was still in complete remission of seminoma with a successfully tapered combination dose of prednisolone and pirfenidone. CONCLUSIONS: Pirfenidone, a novel oral agent with anti-inflammatory and -fibrotic properties, should be considered as a salvage drug for refractory cases of bleomycin-induced lung injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3521-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5547483
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55474832017-08-09 Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma Sakamoto, Koji Ito, Satoru Hashimoto, Naozumi Hasegawa, Yoshinori BMC Cancer Case Report BACKGROUND: Bleomycin-induced lung injury, a major complication of chemotherapy for germ cell tumors, occasionally fails to respond to the standard treatment with corticosteroids and develops into severe respiratory insufficiency. Little is known about salvage treatment for refractory cases. CASE PRESENTATION: A 63-year-old man who had been diagnosed with stage I seminoma and undergone a high orchiectomy 1 year previously developed swelling of his left iliac lymph node and was diagnosed with a recurrence of the seminoma. He was administered a standard chemotherapy regimen of cisplatin, etoposide, and bleomycin. At the end of second cycle, he developed a dry cough and fever that was accompanied by newly-identified bilateral infiltrates on chest X-ray. Despite initiation of oral prednisolone, his exertional dyspnea and decline in pulmonary functions continued to be aggravated. High-dose pulse treatment with methylprednisolone was introduced and improved his symptoms and radiologic findings. However, the maintenance dose of oral prednisolone allowed reactivation of the disease with evidence of newly-developed bilateral lung opacities on high-resolution CT scans. Considering his glucose intolerance and cataracts as complications of corticosteroid treatment, administration of pirfenidone was initiated with the patient’s consent. Pirfenidone at 1800 mg/day was well tolerated, and resolved his symptoms and abnormal opacities on a chest CT scan. Subsequently, the dose of prednisolone was gradually tapered without worsening of the disease. At the most recent follow-up, he was still in complete remission of seminoma with a successfully tapered combination dose of prednisolone and pirfenidone. CONCLUSIONS: Pirfenidone, a novel oral agent with anti-inflammatory and -fibrotic properties, should be considered as a salvage drug for refractory cases of bleomycin-induced lung injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3521-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-07 /pmc/articles/PMC5547483/ /pubmed/28784103 http://dx.doi.org/10.1186/s12885-017-3521-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Sakamoto, Koji
Ito, Satoru
Hashimoto, Naozumi
Hasegawa, Yoshinori
Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
title Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
title_full Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
title_fullStr Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
title_full_unstemmed Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
title_short Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
title_sort pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547483/
https://www.ncbi.nlm.nih.gov/pubmed/28784103
http://dx.doi.org/10.1186/s12885-017-3521-0
work_keys_str_mv AT sakamotokoji pirfenidoneassalvagetreatmentforrefractorybleomycininducedlunginjuryacasereportofseminoma
AT itosatoru pirfenidoneassalvagetreatmentforrefractorybleomycininducedlunginjuryacasereportofseminoma
AT hashimotonaozumi pirfenidoneassalvagetreatmentforrefractorybleomycininducedlunginjuryacasereportofseminoma
AT hasegawayoshinori pirfenidoneassalvagetreatmentforrefractorybleomycininducedlunginjuryacasereportofseminoma